Gut Microbe Molecule TMA Unlocks New Diabetes Treatment Pathway
Published on: Dec. 8, 2025, 11:31 p.m. | Source: Devdiscourse
Researchers have identified the microbial metabolite TMA as a direct blocker of the immune protein IRAK4, reducing inflammation and improving insulin sensitivity. This discovery opens potential new therapeutic avenues for diabetes treatment, highlighting how gut microbes and nutrition collaborate to support metabolic health.
